CTMX
Price
$2.90
Change
+$0.06 (+2.11%)
Updated
Sep 26 closing price
Capitalization
478.25M
39 days until earnings call
NRSN
Price
$1.24
Change
+$0.06 (+5.08%)
Updated
Sep 26 closing price
Capitalization
31.05M
59 days until earnings call
Interact to see
Advertisement

CTMX vs NRSN

Header iconCTMX vs NRSN Comparison
Open Charts CTMX vs NRSNBanner chart's image
CytomX Therapeutics
Price$2.90
Change+$0.06 (+2.11%)
Volume$9.32M
Capitalization478.25M
NeuroSense Therapeutics
Price$1.24
Change+$0.06 (+5.08%)
Volume$237.28K
Capitalization31.05M
CTMX vs NRSN Comparison Chart in %
Loading...
CTMX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NRSN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CTMX vs. NRSN commentary
Sep 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CTMX is a Buy and NRSN is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 28, 2025
Stock price -- (CTMX: $2.90 vs. NRSN: $1.24)
Brand notoriety: CTMX and NRSN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CTMX: 262% vs. NRSN: 30%
Market capitalization -- CTMX: $478.25M vs. NRSN: $31.05M
CTMX [@Biotechnology] is valued at $478.25M. NRSN’s [@Biotechnology] market capitalization is $31.05M. The market cap for tickers in the [@Biotechnology] industry ranges from $98.9B to $0. The average market capitalization across the [@Biotechnology] industry is $1.89B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CTMX’s FA Score shows that 1 FA rating(s) are green whileNRSN’s FA Score has 0 green FA rating(s).

  • CTMX’s FA Score: 1 green, 4 red.
  • NRSN’s FA Score: 0 green, 5 red.
According to our system of comparison, CTMX is a better buy in the long-term than NRSN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CTMX’s TA Score shows that 5 TA indicator(s) are bullish while NRSN’s TA Score has 4 bullish TA indicator(s).

  • CTMX’s TA Score: 5 bullish, 5 bearish.
  • NRSN’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, NRSN is a better buy in the short-term than CTMX.

Price Growth

CTMX (@Biotechnology) experienced а +46.46% price change this week, while NRSN (@Biotechnology) price change was +1.64% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.00%. For the same industry, the average monthly price growth was +9.18%, and the average quarterly price growth was +54.60%.

Reported Earning Dates

CTMX is expected to report earnings on Nov 06, 2025.

NRSN is expected to report earnings on Nov 26, 2025.

Industries' Descriptions

@Biotechnology (+4.00% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CTMX($478M) has a higher market cap than NRSN($31.1M). CTMX YTD gains are higher at: 181.553 vs. NRSN (3.333). CTMX has higher annual earnings (EBITDA): 44.7M vs. NRSN (-8.55M). CTMX has more cash in the bank: 158M vs. NRSN (666K). NRSN has less debt than CTMX: NRSN (19K) vs CTMX (6.89M). CTMX has higher revenues than NRSN: CTMX (141M) vs NRSN (0).
CTMXNRSNCTMX / NRSN
Capitalization478M31.1M1,537%
EBITDA44.7M-8.55M-523%
Gain YTD181.5533.3335,447%
P/E Ratio5.80N/A-
Revenue141M0-
Total Cash158M666K23,724%
Total Debt6.89M19K36,237%
FUNDAMENTALS RATINGS
CTMX: Fundamental Ratings
CTMX
OUTLOOK RATING
1..100
20
VALUATION
overvalued / fair valued / undervalued
1..100
46
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
13
PRICE GROWTH RATING
1..100
35
P/E GROWTH RATING
1..100
82
SEASONALITY SCORE
1..100
30

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CTMXNRSN
RSI
ODDS (%)
Bearish Trend 3 days ago
88%
N/A
Stochastic
ODDS (%)
Bearish Trend 3 days ago
86%
Bullish Trend 3 days ago
89%
Momentum
ODDS (%)
Bullish Trend 3 days ago
81%
Bullish Trend 3 days ago
90%
MACD
ODDS (%)
Bullish Trend 3 days ago
84%
Bullish Trend 5 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
75%
Bullish Trend 3 days ago
86%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
75%
Bullish Trend 3 days ago
84%
Advances
ODDS (%)
Bullish Trend 3 days ago
76%
Bullish Trend 7 days ago
88%
Declines
ODDS (%)
Bearish Trend 12 days ago
87%
Bearish Trend 4 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
88%
Bearish Trend 3 days ago
90%
Aroon
ODDS (%)
Bearish Trend 4 days ago
88%
Bearish Trend 3 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
CTMX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NRSN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
WPP24.040.41
+1.74%
WPP PLC
ITW261.043.15
+1.22%
Illinois Tool Works
FUNC38.120.23
+0.61%
First United Corp
PRO22.93N/A
N/A
Pros Holdings
RENB0.13-0.01
-7.47%
Lunai Bioworks Inc.

CTMX and

Correlation & Price change

A.I.dvisor indicates that over the last year, CTMX has been loosely correlated with BCAB. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if CTMX jumps, then BCAB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CTMX
1D Price
Change %
CTMX100%
+2.11%
BCAB - CTMX
37%
Loosely correlated
+6.22%
RAPT - CTMX
34%
Loosely correlated
+7.89%
KZR - CTMX
34%
Loosely correlated
-2.67%
FATE - CTMX
33%
Loosely correlated
+3.01%
HOWL - CTMX
32%
Poorly correlated
+2.48%
More

NRSN and

Correlation & Price change

A.I.dvisor tells us that NRSN and CTMX have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that NRSN and CTMX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NRSN
1D Price
Change %
NRSN100%
+5.08%
CTMX - NRSN
31%
Poorly correlated
+2.11%
VKTX - NRSN
27%
Poorly correlated
+1.91%
ABCL - NRSN
26%
Poorly correlated
+1.94%
JANX - NRSN
25%
Poorly correlated
+6.71%
DNA - NRSN
24%
Poorly correlated
+2.22%
More